Familial combined hyperlipidemia, metabolic syndrome and cardiovascular disease;Hiperlipidemia familiar combinada, síndrome metabólico y enfermedad cardiovascular

Revista Espanola de Cardiologia

Volumn 59, Issue 11, 2006, Pages 1195-1198

  Martinez Hervás, Sergio ^a   Real, José T ^a   Priego, Antonia ^a   Sanz, Javier ^a   Martín, Jose M ^b   Carmena, Rafael ^a   Ascaso, Juan F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Acute myocardial infarction; Familial combined hypelipidemia; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; INSULIN; LIPID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL DISEASE; FAMILIAL HYPERLIPEMIA; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC DISORDER; NONPARAMETRIC TEST; SURVIVOR;

EID: 33846415144     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095789     Document Type: Article

References (22)

1. Goldstein JL, Hazzard WR, Schrott HG, Wiwerman EL, Motulsky AG. Hyperlipidemia in coronary heart disease: I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973;52:1533-43.
2. Goldstein JL, Schrott HG, Hazzard WR, Wierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease: II. Genetyc analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544-68.
3. Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85: 2025-33.
4. Carmena R. Hiperlipidemia familiar combinada. En: Carmena R, Ordovas JM, editores. Hiperlipidemias: clínica y tratamiento. Barcelona: Doyma; 1999. p. 99-106.
5. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 1990;10:520-30.
6. Ascaso JF, Sales J, Priego A, Merchante A, Carmena-Ramón R, Carmena R. Alteración de la secreción de insulina en la Hiperlipidemia familiar combinada. Med Clin (Barc). 1997;108:530-3.
7. Ascaso JF, Merchante A, Lorente RI, Real JT, Martinez-Valls J, Carmena R. A study of insulin resistance, using the minimal model, in non-diabetic Familial combined hyperlipidemic patients. Metabolism. 1998;47:508-13.
8. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Cuantificación de insulinorresistencia con los valores de insulina basal e índice HOMA en una población no diabética. Med Clin (Barc). 2001;117:530-3.
9. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Geneve: WHO; 1999.
10. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
11. Ascaso JF, Sales J, Merchante A, Real JT, Lorente RI, Martinez-Valls J, et al. Hipertrigliceridemia e insulina plasmática en la hiperlipidemia familiar combinada. Rev Clin Esp. 1997;197:735-9.
12. Ascaso JF, Real JT, Merchante A, Rodrigo A, Carmena R. Lipoprotein phenotype and insulin resistance in patients with Familial combined hyperlipidemia. Metabolism. 2000;49:1627-31.
13. Stout RW. Insulin and atheroma: 20 years perspective. Diabetes Care. 1990;3:631-54.
14. Laakso M, Sarluhnd H, Salonen R, Suhonen M, Pyörälä K, Solonen JT, et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Throm. 1991;11:1068-76.
15. Hargreaves AD, Logan RL, Elton RA, Riemersmel A, Bucknan KD, Oliver MF. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992;94:64-9.
16. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res. 1985;15 Suppl: 41-6.
17. Ascaso JF, Lorente R, Merchante A, Real JT, Priego A, Carmena R. Insulin resistance in patients with familial combined hyperlipidemia and ischemic heart disease. Am J Cardiol. 1997;80:1484-7.
18. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2001;24:1629-33.
19. Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Julian B, Portilla Cordoba DP. Síndrome metabólico como marcador de riesgo cardiovascular en pacientes con diabetes tipo 2. Rev Esp Cardiol. 2004;57:507-13.
20. Hernandez Mijares A, Riera Fortuny C, Martinez Triguero ML, Morillas Ariño C, Cubells Cascales P, Morales Suárez-Varela M. Síndrome metabólico en pacientes con enfermedad coronaria. Resultados usando diferentes criterios diagnósticos. Rev Esp Cardiol. 2004;57:889-93.
21. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
22. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.